These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 29146302)

  • 1. Mechanisms involved in bone resorption regulated by vitamin D.
    Nakamichi Y; Udagawa N; Suda T; Takahashi N
    J Steroid Biochem Mol Biol; 2018 Mar; 177():70-76. PubMed ID: 29146302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. VDR in Osteoblast-Lineage Cells Primarily Mediates Vitamin D Treatment-Induced Increase in Bone Mass by Suppressing Bone Resorption.
    Nakamichi Y; Udagawa N; Horibe K; Mizoguchi T; Yamamoto Y; Nakamura T; Hosoya A; Kato S; Suda T; Takahashi N
    J Bone Miner Res; 2017 Jun; 32(6):1297-1308. PubMed ID: 28177161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Vitamin D Receptor in Osteoblast-Lineage Cells Is Essential for the Proresorptive Activity of 1α,25(OH)2D3 In Vivo.
    Mori T; Horibe K; Koide M; Uehara S; Yamamoto Y; Kato S; Yasuda H; Takahashi N; Udagawa N; Nakamichi Y
    Endocrinology; 2020 Nov; 161(11):. PubMed ID: 32987399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absence of vitamin D receptor in mature osteoclasts results in altered osteoclastic activity and bone loss.
    Starczak Y; Reinke DC; Barratt KR; Ryan JW; Russell PK; Clarke MV; St-Arnaud R; Morris HA; Davey RA; Atkins GJ; Anderson PH
    J Steroid Biochem Mol Biol; 2018 Mar; 177():77-82. PubMed ID: 29107736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamin D action and regulation of bone remodeling: suppression of osteoclastogenesis by the mature osteoblast.
    Baldock PA; Thomas GP; Hodge JM; Baker SU; Dressel U; O'Loughlin PD; Nicholson GC; Briffa KH; Eisman JA; Gardiner EM
    J Bone Miner Res; 2006 Oct; 21(10):1618-26. PubMed ID: 16995817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitamin D receptor in osteoblasts is a negative regulator of bone mass control.
    Yamamoto Y; Yoshizawa T; Fukuda T; Shirode-Fukuda Y; Yu T; Sekine K; Sato T; Kawano H; Aihara K; Nakamichi Y; Watanabe T; Shindo M; Inoue K; Inoue E; Tsuji N; Hoshino M; Karsenty G; Metzger D; Chambon P; Kato S; Imai Y
    Endocrinology; 2013 Mar; 154(3):1008-20. PubMed ID: 23389957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitamin D receptor in chondrocytes promotes osteoclastogenesis and regulates FGF23 production in osteoblasts.
    Masuyama R; Stockmans I; Torrekens S; Van Looveren R; Maes C; Carmeliet P; Bouillon R; Carmeliet G
    J Clin Invest; 2006 Dec; 116(12):3150-9. PubMed ID: 17099775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitamin D receptor expression in mature osteoclasts reduces bone loss due to low dietary calcium intake in male mice.
    Starczak Y; Reinke DC; Barratt KR; Russell PK; Clarke MV; Davey RA; Atkins GJ; Anderson PH
    J Steroid Biochem Mol Biol; 2021 Jun; 210():105857. PubMed ID: 33647520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteoclastic metabolism of 25(OH)-vitamin D3: a potential mechanism for optimization of bone resorption.
    Kogawa M; Findlay DM; Anderson PH; Ormsby R; Vincent C; Morris HA; Atkins GJ
    Endocrinology; 2010 Oct; 151(10):4613-25. PubMed ID: 20739402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated Gα11 expression in osteoblast lineage cells promotes osteoclastogenesis and leads to enhanced trabecular bone accrual in response to pamidronate.
    Dela Cruz A; Grynpas MD; Mitchell J
    Am J Physiol Endocrinol Metab; 2016 May; 310(10):E811-20. PubMed ID: 27006198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of inhibitory action of eldecalcitol, an active vitamin D analog, on bone resorption in vivo.
    Takahashi N
    J Steroid Biochem Mol Biol; 2013 Jul; 136():171-4. PubMed ID: 23220095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stimulation of osteoclast formation by 1,25-dihydroxyvitamin D requires its binding to vitamin D receptor (VDR) in osteoblastic cells: studies using VDR knockout mice.
    Takeda S; Yoshizawa T; Nagai Y; Yamato H; Fukumoto S; Sekine K; Kato S; Matsumoto T; Fujita T
    Endocrinology; 1999 Feb; 140(2):1005-8. PubMed ID: 9927335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The OPG/RANKL/RANK system and bone resorptive disease].
    Liu JZ; Ji ZL; Chen SM
    Sheng Wu Gong Cheng Xue Bao; 2003 Nov; 19(6):655-60. PubMed ID: 15971575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Daily administration of eldecalcitol (ED-71), an active vitamin D analog, increases bone mineral density by suppressing RANKL expression in mouse trabecular bone.
    Harada S; Mizoguchi T; Kobayashi Y; Nakamichi Y; Takeda S; Sakai S; Takahashi F; Saito H; Yasuda H; Udagawa N; Suda T; Takahashi N
    J Bone Miner Res; 2012 Feb; 27(2):461-73. PubMed ID: 22052469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. c-Fos protein as a target of anti-osteoclastogenic action of vitamin D, and synthesis of new analogs.
    Takasu H; Sugita A; Uchiyama Y; Katagiri N; Okazaki M; Ogata E; Ikeda K
    J Clin Invest; 2006 Feb; 116(2):528-35. PubMed ID: 16424941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inferences from genetically modified mouse models on the skeletal actions of vitamin D.
    Goltzman D
    J Steroid Biochem Mol Biol; 2015 Apr; 148():219-24. PubMed ID: 25237033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased bone resorption in Ezh2 myeloid cell conditional knockout mouse model.
    Caviness PC; Gai D; Lazarenko OP; Blackburn ML; Zhan F; Chen JR
    FASEB J; 2023 Jul; 37(7):e23019. PubMed ID: 37272906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for altered osteoclastogenesis in splenocyte cultures from VDR knockout mice.
    Reinke DC; Starczak Y; Kogawa M; Barratt KR; Morris HA; Anderson PH; Atkins GJ
    J Steroid Biochem Mol Biol; 2018 Mar; 177():96-102. PubMed ID: 28765041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogen and testosterone use different cellular pathways to inhibit osteoclastogenesis and bone resorption.
    Michael H; Härkönen PL; Väänänen HK; Hentunen TA
    J Bone Miner Res; 2005 Dec; 20(12):2224-32. PubMed ID: 16294275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitamin D receptor overexpression in osteoblasts and osteocytes prevents bone loss during vitamin D-deficiency.
    Lam NN; Triliana R; Sawyer RK; Atkins GJ; Morris HA; O'Loughlin PD; Anderson PH
    J Steroid Biochem Mol Biol; 2014 Oct; 144 Pt A():128-31. PubMed ID: 24434283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.